Peptic ulcer pathogenesis

Current Opinion in Gastroenterology

Volumn 12, Issue SUPPL. 1, 1996, Pages 24-27

  Arnold, Rudolf ^a   Quina, Mario ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

BACTERIAL INFECTION; DISEASE PREDISPOSITION; DUODENUM ULCER; HELICOBACTER PYLORI; HUMAN; HYPERGASTRINEMIA; INFLAMMATION; INTESTINE METAPLASIA; PATHOGENESIS; PEPTIC ULCER; SHORT SURVEY; STOMACH ACID SECRETION; ULCEROGENESIS;

EID: 0029959205     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199601001-00006     Document Type: Short Survey

References (35)

1. Blaser MJ, Chyou PH, Nomura A: Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 1995, 55:562-565.
2. Pounder RE: The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995, 9(suppl 2):33-54.
3. Sonnenberg A: Temporal trends and geographical variations of peptic ulcer disease. Aliment Pharmacol Ther 1995, 9(suppl 2):3-12.
4. Ashorn M, Miettinen A, Ruuska T, Laippala P, Mäki M: Seroepidemiological study of Helicobacter pylori infection in infancy. Arch Dis Child 1996, 74:F141-F142. H. pylori seroconversion from negative to positive occurs during the first two years of life in 5.6% of children.
5. Sipponen P, Kosunen TU, Samloff OP, Heinonen OP, Siurala M: Rate of Helicobacter pylori acquisition among Finnish Adults. Scand J Gastroenterol 1996, 31:229-232. Overall annual acquisition rate of H. pylori during a 15-year follow-up occurs in 0.44% of individuals. This low rate is similar in all birth cohorts. Together with the high prevalence rates of chronic gastritis these data underline the assumption that H. pylori infection occurs during childhood.
6. Wyatt JI, Rathbone BJ, Sobala GM, Shallcross T, Heatley RV, Axon AT, Dixon MF: Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol 1990, 43:981-986.
7. Gormally JM, Kierce BM, Daly LE, Bourke B, Carroll R, Dumin MT, Drumm B: Gastric metaplasia and duodenal ulcer disease in children infected by Helicobacter pylori. Gut 1996, 38:513-517. The co-existance of gastric metaplasia in the duodenum and H. pylori colonization of the antral mucosa is critical for the development of duodenal ulcer disease in children.
8. Amarapurkar DN, Parikh SS, Prabhu SR, Kairo RH, Desai HG: Is gastric metaplasia essential for duodenal ulcer? J Clin Gastroenterol 1993, 16:6-9.
9. Yang H, Dixon MF, Zuo J Fong F, Zhou D, Corthésy I, Blum A: Helicobacter pylori infection and gastric metaplasia in the duodenum in China. J Clin Gastroenterol 1995, 20:110-112.
10. Khulusi S, Mendall MA, Badve S, Patel P, Finlayson C, Northfield TC: Effect of Helicobacter pylori eradication on gastric metaplasia of the duodenum. Gut 1995, 36:193-197.
11. Khulusi S, Badve S, Patel P, Lloyd R, Marrero JM, Finlayson C, Mendall MA, Northfield TC: Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori gastric acid and ulceration. Gastroenterology 1996, 110:452-458. The extent of duodenal gastric metaplasia is unrelated to the presence or absence of ulceration but results partly because of H. pylori and partly acid.
12. Khulusi, S, Hanky AM, Marrero JM, Patel P, Mendall MA, Badve S, Poulsom R, Elia G, Wright NA, Northfield TC: Expression of trefoil peptides pS2 and human spasmolytic polypeptide in gastric metaplasia at the margin of duodenal ulcers. Gut 1995, 37:205-209.
13. Khulusi S, Mendall MA, Patell, P, Levy J, Badve S, Northfield TC: Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects. Gut 1995, 37:319-324.
14. Feldman M, Richardson CT: Total 24-hour gastric acid secretion in patients with duodenal ulcer. Gastroenterology 1986, 90:540-544.
15. El-Omar EM, Penmann ID, Ardill JES, Chittagalla RS, Howie C, McColl KEL: Helicobacter infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1996, 109:681-691. Patients with duodenal ulcer disease and H. pylori infection reveal markedly increased basal acid output and gastrin-releasing-peptide, i.e. endocrine-stimulated acid output. Both resolve after eradication of the infection.
16. Levi S, Beardshall K, Hadded G, Playford R, Ghosh P, Calam J: Campylobacter pylori and duodenal ulcer: the gastrin link. Lancet 1989, 1:116-118.
17. Graham DY, Opekum A, Lew GM, Klein PD, Walsh JH: Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. The effect of bombesin infusion and urea ingestion. Gastroenterology 1991, 100:1571-1575.
18. Mayer G, Arnold R, Feurle G, Fuchs K, Ketterer H, Track NS, Creutzfeldt W: Influence of feeding and sham feeding upon serum gastrin and gastric acid secretion in control subjects and duodenal ulcer patients. Scand J Gastroent 1974, 6:47-76.
19. Moss SF, Legon S, Bishop AE, Polak JM, Calam J: Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992, 340:930-932.
20. Kaneko H, Nakada K, Mitsuma T, Uchida K, Furusawa A, Meada Y: Helicobacter pylori infection induces a decrease in immunoreactive-somatostatin concentrations of human stomach. Dig Dis Sci 1992, 37:409-416.
21. Odum L, Petersen HD, Andersen IB, Hansen BF, Rehfeld JF: Gastrin and somatostatin in Helicobacter pylori infected antral mucosa. Gut 1994, 35:615-618.
22. Götz JM, Veenendaal RA, Biemond I, Müeller ESM, Veselic M, Lamers CBHW: Serum gastrin and mucosal somatostain in Helicobacter pylori-associated gastritis. Scand J Gastroenterol 1995, 30:1067-1068.
23. Calam J: Helicobacter pylori, acid and gastrin. Eur J Gastroenterol Hepatol 1995, 7:310-317. An excellent overview on the effect of H. pylori on antral gastrin and somatostatin secretion and on the mechanisms of acid secretion.
24. Metz DC, Weber HCh, Orbach M, Strader DB, Lubensky IA, Jensen RT: Helicobacter pylori infection. A reversible cause of hypergastrinemia and hyperchlorhydria which may mimic Zollinger-Ellison syndrome. Dig Dis Sci 1995, 40:153-159. Two patients with hypergastrinaemia and gastric acid hypersecretion mimicking Zollinger-Ellison syndrome were studied. After H. pylori eradication, acid hypersecretion and hypergastrinaemia resolved.
25. Lamers CBH, Ruland CM, Joosten HJM, Verkoogen HCM, van Tongeren JHM, Rehfeld JF: Hypergastrinemia of antral origin in duodenal ulcer. Dig Dis Sci 1978, 23:998-1002.
26. Blaser MJ: Helicobacter pylori phenotypes associated with peptic ulceration. Scand J Gastroenterol 1994, 24(suppl 205):1-5.
27. Tee W, Lambert JR, Dwyer B: Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract disease. J Clin Microbiol 1995, 33:1203-1205.
28. Cover TL, Tummuru MKR, Cao P, Thompson SA, Blaser MJ: Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 1994, 269:10566-10573.
29. Xiang Z, Censini J, Bayelli PF, Telford JL, Figura N, Rappuoli R, Covacci A: Analysis of expression of CagA and vacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995, 63:94-98. The message of this important paper is expressed in its title.
30. Atherton JC, Coa P, Peek RM Jr, Tummura MKR, Blaser MJ, Cover TL: Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. J Biol Chem 1995, 270:17771-17772. The existence of ulcerogenic H. pylori strains is strongly supported by the data of this paper which demonstrates the presence of divergencies in the vacA signal sequence.
31. De Bernard M, Papini E, de Rlippis V, Gottardi E, Telford J, Manetti R, Fontana A, Rappuoli, R, Montecucco C: Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant. J Biol Chem 1995, 270:23937-23941.
32. Rautelin H, Blomberg B, Järnerot G, Danielsson D: Non-opsonic activation of neutrophils and cytotoxin production by Helicobacter pylori: ulcergenic markers. Scand J Gastroenterol 1994, 29:128-131.
33. Crabtree JE, Farmery SM, Lindley ISD, Figura N, Peichl P, Tompkins DS: CagA/cytotoxic strains of Helicobacter pylori and interleukin 8 in gastric epithelial cell lines. J Clin Pathol 1994, 47:945-950.
34. Leoci C, Ierardi E, Chiloiro M, Piccioli E, Di Matteo G, Misciagna G, Girogio I: Incidence and risk factors of duodenal ulcer. A retrospective cohort study. J Clin Gastroenterol 1995, 20:104-109.
35. Lanas AI, Remacha B, Esteva F, Sàinz R: Risk factors associated with refractory peptic ulcers. Gastroenterology 1995, 109:1124-1133. This study highlights NSAIDs and analgesic abuse as the most important exogenous factors and H. pylori as the most important intrinsic factor for refractory peptic ulcer disease.